Key result
Oxidized DNA in extracellular vesicles released during Trypanosoma cruzi infection activates the PARP1-cGAS-NF-κB pathway, driving proinflammatory macrophage activation that is attenuated by PARP1 inhibition.
Why the study?
Trypanosoma cruzi causes Chagas cardiomyopathy, but the role of extracellular vesicles in shaping macrophage responses during progressive Chagas disease remained unclear.
p-value: p=<0.001
Oxidized DNA in extracellular vesicles from T. cruzi infection activates the PARP1-cGAS-NF-κB pathway, suggesting PARP1 and cGAS inhibitors could be potential therapeutic targets for chronic inflammation in Chagas cardiomyopathy.
PARP1 inhibition attenuates T. cruzi-driven macrophage inflammation in vitro; leaves open whether cGAS-PARP1 targeting alters Chagas cardiomyopathy progression.
Trypanosoma cruzi (T. cruzi) is the etiological agent of Chagas cardiomyopathy. In the present study, we investigated the role of extracellular vesicles (Ev) in shaping the macrophage (Mφ) response in progressive Chagas disease (CD). We purified T. cruzi Ev (TcEv) from axenic parasite cultures, and T. cruzi-induced Ev (TEv) from the supernatants of infected cells and plasma of acutely and chronically infected wild-type and Parp1-/- mice. Cultured (Raw 264.7) and bone-marrow Mφ responded to TcEV and TEv with a profound increase in the expression and release of TNF-α, IL-6, and IL-1β cytokines. TEv produced by both immune (Mφ) and non-immune (muscle) cells were proinflammatory. Chemical inhibition or genetic deletion of PARP1 (a DNA repair enzyme) significantly depressed the TEv-induced transcriptional and translational activation of proinflammatory Mφ response. Oxidized DNA encapsulated by TEv was necessary for PARP1-dependent proinflammatory Mφ response. Inhibition studies suggested that DNA-sensing innate immune receptors (cGAS>>TLR9) synergized with PARP1 in signaling the NFκB activation, and inhibition of PARP1 and cGAS resulted in >80% inhibition of TEv-induced NFκB activity. Histochemical studies showed intense inflammatory infiltrate associated with profound increase in CD11b+CD68+TNF-α+ Mφ in the myocardium of CD wild-type mice. In comparison, chronically infected Parp1-/- mice exhibited low-to-moderate tissue inflammation, >80% decline in myocardial infiltration of TNF-α+ Mφ, and no change in immunoregulatory IL-10+ Mφ. We conclude that oxidized DNA released with TEv signal the PARP1-cGAS-NF-κB pathway of proinflammatory Mφ activation and worsens the chronic inflammatory pathology in CD. Small molecule antagonists of PARP1-cGAS signaling pathway would potentially be useful in reprogramming the Mφ activation and controlling the chronic inflammation in CD.
No takes yet. Share an insight, caveat, or question.
Choudhuri et al. (2020) studied Chagas disease. PARP1 inhibition (iniparib or genetic deletion) vs. Vehicle/Wild-type was evaluated on Proinflammatory cytokine release (TNF-α, IL-6, IL-1β) and NF-κB activity (p=<0.001). Oxidized DNA in extracellular vesicles released during Trypanosoma cruzi infection activates the PARP1-cGAS-NF-κB pathway, driving proinflammatory macrophage activation that is attenuated by PARP1 inhibition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: